Technologies

Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer

  • by

SEOUL, Republic of Korea, September 15, 2026 — The phase III TAISHAN-302 trial found that tambotatug pelitecan (Tam-Peli, YL201), a novel anti-B7-H3 antibody-drug conjugate developed by MediLink Therapeutics, significantly improved overall survival, progression-free survival and… Read More »Phase III TAISHAN-302 Trial Shows Tam-Peli Significantly Improves Survival in Relapsed Small-Cell Lung Cancer

Tokenization Is Bringing Traditional Markets On-Chain — and DeFi May Be Entering Its Next Growth Phase

  • by

Nasdaq’s latest investment in crypto-market infrastructure is another signal that asset tokenization is moving closer to mainstream finance. Lvvas sees the convergence of tokenized assets, stablecoin settlement and decentralized applications as a potential foundation for… Read More »Tokenization Is Bringing Traditional Markets On-Chain — and DeFi May Be Entering Its Next Growth Phase